We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna Starts Phase 1 Trial of ‘Next Generation’ COVID-19 Vaccine
Moderna Starts Phase 1 Trial of ‘Next Generation’ COVID-19 Vaccine
Moderna announced that it has dosed the first participants in its phase 1 trial of mRNA-1283, its “next generation” COVID-19 vaccine candidate that’s being developed to have more relaxed temperature requirements for easier distribution and administration.